Padilla, L., et al. The challenge of one billion adjuvanted vaccine doses: evaluating scalability, sustainability, and supply capacity of Quillaja saponin QS-21 for large-scale vaccine demand. Front Immunol, 2026 Apr 17, 17:1813847. PMID: 42079571
This original paper from Desert King provides a comprehensive evaluation of the scalability, sustainability, and supply capacity of QS-21, a highly potent saponin adjuvant derived from Quillaja saponaria. The study emphasizes the critical role of QS-21 in supporting the growing global demand for adjuvanted vaccines, potentially exceeding one billion doses.
Uniquely, the paper synthesizes historical, chemical, ecological, and technological perspectives to address the urgent challenge of sustainable QS-21 production. It explores the current dependence on wild forest extraction in Chile while evaluating emerging alternatives such as plantation forestry, plant cell culture, engineered microorganisms, and chemical synthesis. The significance of this work lies in its balanced analysis of meeting large-scale vaccine demand while preserving ecological resources, ultimately providing a roadmap for a reliable, scalable, and environmentally sustainable QS-21 supply chain for global immunization efforts.
The paper presents key data showing that the current global supply capacity of GMP-grade QS-21 is approximately 10 kg per year, primarily sourced from wild Chilean forests. This volume is estimated to support around 200 million doses of malaria vaccine or 400 million doses of tuberculosis vaccine, assuming QS-21 doses of 50 μg and 25 μg, respectively. The authors estimate that achieving one billion vaccine doses would require approximately 50 kg of QS-21 annually.
To address this challenge, the study analyzes several production strategies, including harvesting from wild trees, clonal plantation forestry, plant cell culture, and chemical synthesis. The findings suggest that sustainably managed wild forest harvesting could potentially yield around 50 kg of QS-21 per year; however, increasing global demand will likely require more scalable solutions such as plantation forestry and biotechnological production systems.
The paper also highlights that extraction and chromatographic purification from natural sources currently remains the most feasible large-scale production method. At the same time, emerging technologies such as plant cell culture and chemical synthesis are identified as promising long-term alternatives, although they still face important technical and economic barriers to industrial scale-up.
Click here to access the full scientific paper.
